RECENT DEVELOPMENTS IN QUERCETIN-LOADED NANOPARTICLES FOR CANCER TARGETING

Ranjan Kumar Singh; J Pavan Kumar; Chennu MM Prasada Rao; Rajeswari Tanniru; Ajay Garg

doi:10.61280/tjpls.v12i1.174

Ranjan Kumar Singh Faculty School of Pharmacy, Raffles University, Neemrana, Raj-301705
J Pavan Kumar Research Scholar, School of Pharmacy, Raffles University, Neemrana, Raj-301705
Chennu MM Prasada Rao Faculty School of Pharmacy, Raffles University, Neemrana, Raj-301705
Rajeswari Tanniru Faculty School of Pharmacy, Raffles University, Neemrana, Raj-301705
Ajay Garg Faculty School of Pharmacy, Raffles University, Neemrana, Raj-301705

10.61280/tjpls.v12i1.174

Keywords:

Quercetin, Nanoparticles, Therapeutic potential, Tumors, Mechanism

Abstract

Quercetin, a dietary polyphenol, has demonstrated anticancer properties across several malignancies, including pancreatic cancer, breast cancer, and melanoma. Quercetin is a naturally occurring bioflavonoid found in fruits, vegetables, seeds, berries, and tea. The cancer-preventive properties of quercetin are well established, attributed to its anti-inflammatory, anti-proliferative, and anti-angiogenic effects. Nonetheless, the inadequate water solubility and transport, chemical instability, brief half-life, and low bioavailability of quercetin restrict its therapeutic use in cancer chemoprevention. A comprehensive understanding of the molecular mechanisms governing controlled and regulated drug delivery is crucial for developing innovative and effective therapeutics. To surmount the accessibility constraints of quercetin, it may be administered as nano-conjugated quercetin. Nano-conjugated quercetin has garnered significant interest owing to its regulated drug release, prolonged retention in tumors, improved anticancer efficacy, and potential for therapeutic application. This paper presents an overview of quercetin's effects on cancer cells and the mechanisms behind these actions. We also examine the prospective usage of nanoparticles as nanocarriers in medicine delivery systems. This review can summarize the recent developments in quercetin-loaded Nanoparticles for Cancer treatment.

Downloads

Download data is not yet available.

References

Rather RA, Bhagat M. Quercetin as an innovative therapeutic tool for cancer chemoprevention: Molecular mechanisms and implications in human health. Cancer Med. 2020;9(24):9181–92.

Vinayak M, Maurya AK. Quercetin Loaded Nanoparticles in Targeting Cancer: Recent Development. Anticancer Agents Med Chem. 2019;19(13):1560–76.

Smith AJ, Oertle J, Warren D, Prato D. Quercetin: A Promising Flavonoid with a Dynamic Ability to Treat Various Diseases, Infections, and Cancers. J Cancer Ther. 2016;07(02):83–95.

Panthı VK, Kaushal S, Adhıkarı B, Basnet N, Chaudhary D, Pajarulı RR, et al. A Review of Quercetin: Anti-Cancer Activity. Int J Innov Res Rev. 2020;4(1):1–7.

Chirumbolo S. Quercetin in cancer prevention and therapy. Integr Cancer Ther. 2013;12(2):97–102.

Silva D, Gomes JHR;, Da Silva TA, Gomes JHR, De Bulhões LCG, Neto RMS, et al. Therapeutic Potential of Quercetin Based on Nanotechnology: A Review. Rev Virtual Quim [Internet]. 2019;11(4). Available from: http://rvq.sbq.org.br

Vafadar A, Shabaninejad Z, Movahedpour A, Fallahi F, Taghavipour M, Ghasemi Y, et al. Quercetin and cancer: New insights into its therapeutic effects on ovarian cancer cells. Cell Biosci [Internet]. 2020;10(1):1–17. Available from: https://doi.org/10.1186/s13578-020-00397-0

Yadav R, Chawra HS, Dubey G, Alam S, Kumar V, Sharma P, et al. Herbal based nanoparticles as a possible and potential treatment of cancer : a review. Explor Target Anti-tumor Ther. 2025;1–28.

Asgharian P, Tazekand AP, Hosseini K, Forouhandeh H, Ghasemnejad T, Ranjbar M, et al. Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. Cancer Cell Int [Internet]. 2022;22(1):1–20. Available from: https://doi.org/10.1186/s12935-022-02677-w

Shahbaz M, Naeem H, Momal U, Imran M, Alsagaby SA, Al Abdulmonem W, et al. Anticancer and apoptosis inducing potential of quercetin against a wide range of human malignancies. Int J Food Prop [Internet]. 2023;26(1):2590–626. Available from: https://doi.org/10.1080/10942912.2023.2252619

Asgharian P, Tazehkand AP, Soofiyani SR, Hosseini K, Martorell M, Tarhriz V, et al. Quercetin Impact in Pancreatic Cancer: An Overview on Its Therapeutic Effects. Oxid Med Cell Longev. 2021;2021.

Biswas P, Dey D, Biswas PK, Rahaman TI, Saha S, Parvez A, et al. A Comprehensive Analysis and Anti-Cancer Activities of Quercetin in ROS-Mediated Cancer and Cancer Stem Cells. Int J Mol Sci. 2022;23(19).

Mirazimi SMA, Dashti F, Tobeiha M, Shahini A, Jafari R, Khoddami M, et al. Application of Quercetin in the Treatment of Gastrointestinal Cancers. Front Pharmacol. 2022;13(April):1–25.

Tang SM, Deng XT, Zhou J, Li QP, Ge XX, Miao L. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed Pharmacother [Internet]. 2020;121(July 2019):109604. Available from: https://doi.org/10.1016/j.biopha.2019.109604

Nam JS, Sharma AR, Nguyen LT, Chakraborty C, Sharma G, Lee SS. Application of bioactive quercetin in oncotherapy: From nutrition to nanomedicine. Molecules. 2016;21(1):1–23.

Mohamed JMM, Ahmad F, El-Sherbiny M, Al Mohaini MA, Venkatesan K, Alrashdi YBA, et al. Optimization and characterization of quercetin-loaded solid lipid nanoparticles for biomedical application in colorectal cancer. Cancer Nanotechnol [Internet]. 2024;15(1):1–17. Available from: https://doi.org/10.1186/s12645-024-00249-3

Saha C, Kaushik A, Das A, Pal S, Majumder D. Anthracycline drugs on modified surface of quercetin-loaded polymer nanoparticles: A dual drug delivery model for cancer treatment. PLoS One. 2016;11(5):1–15.

Kashif M, Ali M, Bushra, Naz S, Amir J, Murad S, et al. Formulation development and characterization of quercetin loaded poly caprolactone nanoparticles for tumors. Brazilian J Sci. 2024;3(2):82–92.

Lotfi N, Yousefi Z, Golabi M, Khalilian P, Ghezelbash B, Montazeri M, et al. The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update. Front Immunol. 2023;14(February):1–21.